We are delighted to invite you to take part in the 2nd Biomarker Meeting: Personalized Reproductive Medicine 2014 themed “Biomarkers for the Assessment of Ovarian Reserve, Gametes, Embryos, Endometrium and Pregnancy” will take place on April 10 – 12, 2014 in Valencia, Spain at the Sercotel Sorolla Palace.
The aim of the Meeting is to provide the Human Reproductive Field state of the art developments in personalized medicine. We will do so by using novel technologies that allow us to improve our clinical success, using biomarkers for the majority of steps in the reproductive process and beyond in pregnancy.
The participants will be informed of the existing and rapidly developing diagnostic technologies [deep-sequencing, genomics, transcriptomics, proteomics and metabolomics], which may help us better assess ovarian reserve, gametes, embryos and endometrium in order to increase success in our clinical procedures. Also the pathological implications and biomarkers implicated in each of these processes will be carefully analyzed.
Finally, a comprehensive update of translational research in the area will be a major focal point for the conference.
Objectives of the Meeting
- Understand the need for new techniques for embryo assessment
- Describe the current strategies for the evaluation of human gametes and embryos
- Describe and understand new technologies for genetic and metabolic screening of the human embryo and its environment
- Understand the potential benefits of emerging invasive and non-invasive techniques for embryo assessment
- Recognize the genetic and proteomic screening of the endometrium
- Be aware of current diagnostic capabilities at the clinical level of the new technologies
The Ovarian Reserve and Oocytes
- Embryo Diagnostics
- The Sperm
- The Endometrium in Health and Disease
- Biomarkers for Normal and Pathological Pregnancy
- Clinical Translation: The Translators. What Biotech Companies are on the Horizon to Help Us?
Obstetricians, gynecologists, reproductive endocrinology and infertility specialists, embryologists, basic scientists, nurses, health institution managers and post graduate students involved in reproductive health will benefit from this meeting.
- Edward Abrahams, USA
- Christopher Barratt, UK
- Hilary Critchley, UK
- Thomas D’Hooghe, Belgium
- Francisco Dominguez, Spain
- David Gardner, Australia
- Nicolás Garrido, Spain
- Andrew Horne, UK
- Julio Martin, Spain
- Scott Nelson, UK
- Pera Renee Reijo, USA
- Carmen Rubio, Spain
- Denny Sakkas, USA
- Carlos Simón, Spain
- Ali Tinazli, USA
- Nathan Treff, USA
- Dagan Wells, UK
Continuing Medical Education Accreditation points (CME)
The 2nd Biomarker Meeting: Personalized Reproductive Medicine has submitted for CME accreditation via the European Accreditation Council for Continuing Medical Education (EACCME). The accreditation will be in compliance with EBU/UEMS regulations — 1 credit per hour, with a maximum of 6 credits per day. Both the EBU and the EACCME are the institutions of the European Union of Medical Specialists (UEMS). All CME events accredited by the EBU have the EACCME endorsement. The EBU/EACCME CME Credits are recognized by National Accreditation Authorities.
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
All CME activities approved by the EBU/EACCME are valid for recognition by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA.